Clinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study

Sadeleştirilmiş öğe sayfası
dc.contributor.authorYildirim, Hasan Cagri
dc.contributor.authorMutlu, Emel
dc.contributor.authorChalabiyev, Elvin
dc.contributor.authorOzen, Mirac
dc.contributor.authorKeskinkilic, Merve
dc.contributor.authorOn, Sercan
dc.contributor.authorCelebi, Abdussamet
dc.contributor.authorDursun, Bengu
dc.contributor.authorAcar, Omer
dc.contributor.authorKahraman, Seda
dc.contributor.authorAykan, Musa Baris
dc.contributor.authorKaman, Omur
dc.contributor.authorDogan, Akif
dc.contributor.authorErdogan, Atike Pinar
dc.contributor.authorCelayir, Ozde Melisa
dc.contributor.authorGunenc, Damla
dc.contributor.authorGuven, Deniz Can
dc.contributor.authorBayoglu, Ibrahim Vedat
dc.contributor.authorYavuzsen, Tugba
dc.contributor.authorHacibekiroglu, Ilhan
dc.contributor.authorInanc, Mevlude
dc.contributor.authorKilickap, Saadettin
dc.contributor.authorYalcin, Suayib
dc.contributor.authorAksoy, Sercan
dc.date.accessioned2025-10-16T15:16:46Z
dc.date.issued2022
dc.identifier.doi10.1016/j.breast.2022.09.009
dc.identifier.otherWOS:000875350600003
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/6779
dc.publisherCHURCHILL LIVINGSTONE
dc.sourceBREAST
dc.subjectMale breast cancer
dc.subjectPalbociclib
dc.subjectRibociclib
dc.titleClinical outcomes of cyclin-dependent kinase 4-6 (CDK 4-6) inhibitors in patients with male breast cancer: A multicenter study
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS